Saturday 17 October 2026
Export WAY’s income statement to Excel — free account
Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS grew 10.5%, free cash flow fell 52.4% and total debt rose 18.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
27.36
0.88
−3.12%
Follow WAY
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 51.17 |
Piotroski F-Score |
— | — | 6 | 6 |
Altman Z-Score |
— | — | 2.49 | 2.16 |
P/S ratio |
0.00 | 0.00 | 5.83 | 5.30 |
Altman Z″-Score (non-manufacturers) |
1.04 | 1.06 | 2.51 | 2.47 |
P/FCF ratio |
71.73 | 71.73 | 38.61 | 20.58 |
P/Operating CF |
234.73 | 234.73 | 84.95 | 87.45 |
Beneish M-Score |
— | (2.40) | (2.47) | (2.41) |
P/B ratio |
1.23 | 1.23 | 1.79 | 1.50 |
Price to Tangible BV |
1.23 | 1.23 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 6.93 | 6.55 |
EV/EBITDA |
0.00 | 0.00 | 20.81 | 18.34 |
EV/Operating CF |
75.62 | 75.62 | 38.53 | 23.24 |
EV/FCF |
133.94 | 133.94 | 45.90 | 25.42 |
Quick Ratio |
1.80 | 1.44 | 2.42 | 1.31 |
Current Ratio |
2.13 | 1.80 | 2.55 | 1.41 |
Net Debt/EBITDA |
7.66 | 6.64 | 3.31 | 3.49 |
Debt/Assets |
47.69% | 48.66% | 27.17% | 25.46% |
Debt/Equity |
1.06 | 1.09 | 0.40 | 0.38 |
Asset Turnover |
0.00 | 0.17 | 0.21 | 0.21 |
Operating CF/Net income |
(1.99) | (1.00) | (8.88) | 2.76 |
Capex/Depreciation |
(0.09) | (0.12) | (0.14) | (0.18) |
Interest Coverage |
0.58 | 0.69 | 0.85 | 3.22 |
| 0.00% | (2.47%) | (0.75%) | 3.22% | |
| 0.00% | (1.11%) | (0.42%) | 2.16% | |
ROIC |
1.31% | 2.10% | 1.88% | 2.97% |
Return on Tangible Assets |
(30.00%) | (32.12%) | (7.03%) | 78.94% |
Average Days of Receivables |
57.70 | 61.32 | 57.28 | 60.92 |
Research and Development Expense of Revenue |
4.65% | 4.47% | 5.17% | 4.97% |
Selling, General and Administrative Expense of Revenue |
26.18% | 23.69% | 28.48% | 27.89% |
Intangible Assets out of Total Assets |
0.92 | 0.92 | 0.89 | 0.92 |
Share Based Compensation of Revenue |
1.14% | 1.12% | 5.77% | 3.83% |
Graham Net Nets |
(0.92) | (0.92) | (0.20) | (0.27) |
Graham Number |
0.00 | 0.00 | 0.00 | 17.72 |
Earnings Yield |
(2.59%) | (2.59%) | (0.55%) | 1.95% |
Free Cash Flow Yield |
1.39% | 1.39% | 2.59% | 4.86% |
Revenue per Share |
5.79 | 6.50 | 6.29 | 6.18 |
Operating CF per Share |
0.84 | 0.42 | 1.13 | 1.74 |
Capex per Share |
(0.14) | (0.18) | (0.18) | (0.15) |
Free Cash Flow per Share |
0.70 | 0.25 | 0.95 | 1.59 |
Cash per Share |
0.60 | 0.37 | 1.36 | 0.57 |
Shareholders Equity per Share |
17.31 | 16.85 | 20.54 | 21.80 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.31 | 16.85 | 20.54 | 21.80 |
Free Cash Flow |
85.20 | 29.94 | 142.50 | 283.19 |
Working Capital |
115.69 | 98.56 | 225.41 | 90.35 |
Capital Expenditures |
(17.43) | (21.52) | (27.27) | (26.48) |
Net Current Asset Value |
(2,370.26) | (2,310.99) | (1,126.18) | (1,597.86) |
EV/EBIT |
0.00 | 0.00 | 52.87 | 28.87 |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 44.47 | 23.37 |
| Other line items | ||||
Depreciation/Fixed assets |
3.46 | 3.05 | 4.08 | 2.77 |
Cash ROIC |
1.93% | 0.69% | 3.15% | 5.19% |
Accounts Receivable Turnover |
0.00 | 6.47 | 6.72 | 6.63 |
Accounts Payable Turnover |
0.00 | 6.79 | 6.80 | 7.08 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
47.72 | 66.47 | 54.76 | 53.41 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 122.17 | 140.49 | 165.77 |
Average Payables |
— | 36.79 | 46.42 | 49.16 |
Average Assets |
— | 4,638.68 | 4,579.99 | 5,181.05 |
Average Common Equity |
— | 2,078.08 | 2,564.86 | 3,479.31 |
Columns are period end dates